NCT07690839Not yet recruiting
Pre-Clinic Visit Online Education for Thyroid Cancer
A Randomized Controlled Trial Evaluating Educational Resources for Patients With Thyroid Cancer
Source: ClinicalTrials.gov · Last updated 1 Sept 2026
Brief summary (registry, in English)
Through a pilot randomized controlled trial (RCT), we aim to test the feasibility and preliminary impact of two online educational resources among adult patients with thyroid cancer. Each online program can be accessed on the patient's personal device, and will be provided to the patient following a diagnosis of thyroid cancer but before meeting with their surgeon to discuss treatment options. The goal of the resource is to educate patients on the various treatment options for thyroid cancer prior to surgical consultation, so that clinic visit time can be better utilized to discuss patient questions and priorities, and support shared decision making. Clinical (TC-MAX; thyroid cancer related anxiety) and behavioral outcomes (decisional conflict, shared-decision making, treatment decision) will be assessed via online surveys 1-day and 14-days post-visit.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 2 Jul 2026
- Start date
- Aug 2027
- Primary completion date
- Jul 2028
- Lead sponsor
- Cedars-Sinai Medical Center
- Diseases
- Thyroid cancer
- NCT number
- NCT07690839
What you commit to
- Study type: Interventional
- Planned participants: 60
- From Aug 2027 to the primary completion date, Jul 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cognitive impairment or other condition that, in the opinion of the investigators, would interfere with protocol participation
- Recurrent thyroid cancer case
Other
- Has nodule \>2cm in size, or with non-papillary thyroid carcinoma histology
- High-grade or poorly differentiated papillary thyroid carcinoma (PTC) variants
- Central or lateral neck lymphadenopathy suspicious for PTC
- Unfavorable nodule location, to be determined by the surgeon (e.g. Near dorsal surface (by recurrent laryngeal nerve); adjacent to trachea (risk of cartilage invasion)
Who the study is looking for
- Newly diagnosed with either:
- ≤2cm Bethesda 6 thyroid nodule (papillary thyroid carcinoma) (T1N0)
- ≤2cm Bethesda 5 thyroid nodule
- ≤2cm Bethesda 3-4 thyroid nodule with molecular testing that confers \>75% risk of malignancy
- Able to understand and complete questionnaires independently in English
- Access to an internet-enabled device for online surveys and intervention access
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.